| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.094 | 0.09 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |